Progestin & Progesterone belong to the progestogen class of steroid hormones. They are available both as natural and synthetic steroid hormones. Progesterone is a natural female hormone. Progesterone is also called pregnancy hormone and is the most important progestogen in the body. Progesterone are endogenous steroids secreted by corpus luteum, produced during the second half of menstrual cycle. Their main functions are the regulation of the menstrual cycle, embryogenesis, and maintenance of pregnancy. Low level of progesterone may result in miscarriage or fetal demise. Progesterone is used with estrogen as a hormone replacement therapy for the treatment of menopause in women. Progestin is a synthetic form of progesterone and is used in hormonal birth control and menstrual cycle. Progestin is available as oral tablets, intramuscular injections, and in solution forms. Progestin has similar functions to those of natural progesterone, but they are structurally different. Progestin are available under a brand names, Aygestin, Camila, Crinone, Errin, Prometrium, etc. Progestin are used worldwide and are contained in all birth control pills.
The global progestin & progesterone market is expected to show promising growth in the next few years because of their advanced way of treatment. Rise in incidence of Amenorrhea, which is the absence of menstrual periods, and increase in cases of infertility treatment in women, uterine dying, breast cancer, etc. are driving the global progestin & progesterone market. In combination with estrogen, progesterone is used as a hormone replacement therapy in the treatment of menopausal issues. Demand for progesterone is driven by the efficacy of progesterone in reducing breast pain and in the treatment of uterine tumor and other indications. Synthetic progesterone are used in the treatment of various indications. Other factors driving the growth of the progestin & progesterone market are increasing funding initiatives, rising trend of home health care, and infrastructure development in the health care industry across the globe. However, lack of awareness regarding accessibility of progestin & progesterone is restraining the growth of the market. Certain side-effects, such as, severe breast pain, blurred vision, vaginal bleedings, joint pains, headaches, dizziness, convulsions, and constipations pose major challenges to the progestin & progesterone market. Nevertheless, key players foresee opportunities to invest in the progestin & progesterone market due to the effective results produced by their application.
The global progestin & progesterone market can be segmented based on application, route of administration, distribution channels, and others. Based on application, the market can be classified into hormone therapy, pregnancy support, premenstrual syndrome, contraception, fertility support, breast cancer, and gynecological disorders. In terms of route of administration, the progestin and progesterone market can be divided into oral, injectable, and others. Progestin and progesterone are also available as capsules, tablets, gel, and others. Based on distribution channel, the progestin & progesterone market caters to hospital pharmacies, online pharmacies, and retail pharmacies. In terms of region, the global progestin & progesterone market can be segmented into North America, Europe, Asia Pacific, Middle East & Africa, and Latin America. North America dominates the global progestin & progesterone market owing to rising consumption of progestin & progesterone, increasing incidences of menstrual cycle issues, hormonal replacement, lifestyle disorders, and technological advancement. North America is followed by Asia Pacific and Europe, in terms of leading the global progestin & progesterone market. Asia Pacific is likely to be the fastest growing market for progestin & progesterone in the near future owing to increasing prevalence of chronic diseases and infertility in the region.
Major players operating in the global progestin & progesterone market include Pfizer Inc., GlaxoSmithKline plc, Solvay, Merck KGaA, ALLERGAN, Sanofi, Kaitai Hormone, Teva pharmaceuticals Industries Ltd., Zhejiang Xianju Pharmaceutical Co Ltd., and Chenggu Zhenhua Bio-Tech.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.